AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Marttunen, MB Hietanen, P Pyrhonen, S Tiitinen, A Ylikorkala, O
Citation: Mb. Marttunen et al., A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy, MATURITAS, 39(3), 2001, pp. 217-225

Authors: Marttunen, MB Cacciatore, B Hietanen, P Pyrhonen, S Tiitinen, A Wahlstrom, T Ylikorkala, O
Citation: Mb. Marttunen et al., Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women, BR J CANC, 84(7), 2001, pp. 897-902

Authors: Hietanen, P Aro, AR Holli, K Absetz, P
Citation: P. Hietanen et al., Information and communication in the context of a clinical trial, EUR J CANC, 36(16), 2000, pp. 2096-2104

Authors: Albanes, D Malila, N Taylor, PR Huttunen, JK Virtamo, J Edwards, BK Rautalahti, M Hartman, AM Barrett, MJ Pietinen, P Hartman, TJ Sipponen, P Lewin, K Teerenhovi, L Hietanen, P Tangrea, JA Virtanen, M Heinonen, OP
Citation: D. Albanes et al., Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland), CANC CAUSE, 11(3), 2000, pp. 197-205

Authors: Virtamo, J Edwards, BK Virtanen, M Taylor, PR Malila, N Albanes, D Huttunen, JK Hartman, AM Hietanen, P Maenpaa, H Koss, L Nordling, S Heinonen, OP
Citation: J. Virtamo et al., Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland), CANC CAUSE, 11(10), 2000, pp. 933-939

Authors: Marttunen, MB Hietanen, P Tiitinen, A Viinikka, L Ylikorkala, O
Citation: Mb. Marttunen et al., Antiestrogens reduce plasma levels of endothelin-1 without affecting nitrate levels in breast cancer patients, GYNECOL END, 14(1), 2000, pp. 55-59

Authors: Holli, K Valavaara, R Blanco, G Kataja, V Hietanen, P Flander, M Pukkala, E Joensuu, H
Citation: K. Holli et al., Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3487-3494

Authors: Marttunen, MB Andersson, S Hietanen, P Karonen, SL Koistinen, HA Koivisto, VA Tiitinen, A Ylikorkala, O
Citation: Mb. Marttunen et al., Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients, MATURITAS, 35(2), 2000, pp. 175-179

Authors: Pyrhonen, S Salminen, E Ruutu, M Lehtonen, T Nurmi, M Tammela, T Juusela, H Rintala, E Hietanen, P Kellokumpu-Lehtinen, PL
Citation: S. Pyrhonen et al., Prospective randomized trial of interferon alfa-2a plus vinblastine versusvinblastine alone in patients with advanced renal cell cancer, J CL ONCOL, 17(9), 1999, pp. 2859-2867

Authors: Marttunen, MB Hietanen, P Titinen, A Roth, HJ Viinikka, L Ylikorkala, O
Citation: Mb. Marttunen et al., Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer, CALCIF TIS, 65(5), 1999, pp. 365-368

Authors: Hietanen, P Teerenhovi, L Joensuu, H
Citation: P. Hietanen et al., Intensified adjuvant cyclophosphamide, methotrexate and 5-fluorouracil therapy: A dose-finding study for ambulatory patients with breast cancer, ONCOL-BASEL, 56(2), 1999, pp. 103-109

Authors: Joensuu, H Holli, K Heikkinen, M Suonio, E Aro, AR Hietanen, P Huovinen, R
Citation: H. Joensuu et al., Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: A prospective randomized trial, J CL ONCOL, 16(12), 1998, pp. 3720-3730
Risultati: 1-12 |